Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.orchidpharma.com | |
Market Cap | 2,601.89 Cr. | |
Enterprise Value(EV) | 2,902.61 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 13.95 | Trailing Twelve Months Ending 2023-06 |
Price-Earning Ratio (PE) | 36.78 | Trailing Twelve Months Ending 2023-06 |
Industry PE | 37.50 | Trailing Twelve Months Ending 2023-06 |
Book Value / Share | 216.77 | Trailing Twelve Months Ending 2023-06 |
Price to Book Value | 2.37 | Calculated using Price: 513.00 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 5.07 Cr. | 50,719,105 Shares |
FaceValue | 10 | |
About Orchid Pharma Ltd. | ||
Orchid Chemicals & Pharmaceuticals (Orchid) is pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. The company was Incorporated in the year 1992 as a 100% export-oriented unit (EOU). |
1 Day |
|
-0.39% |
1 Week |
|
-3.33% |
1 Month |
|
-11.51% |
3 Month |
|
+13.48% |
6 Month |
|
+29.81% |
1 Year |
|
+51.39% |
2 Year |
|
+23.57% |
5 Year |
|
+7488.76% |
10 Year |
|
+1032.45% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -55.58 | -147.51 | -423.17 | -13.43 | -8.75 | 8.27 | ||||
Return on Capital Employed (%) | 4.17 | -0.06 | -6.93 | -3.46 | 3.08 | -6.47 | -3.53 | -2.32 | 9.11 | |
Return on Assets (%) | -4.53 | -7.05 | -13.59 | -10.88 | 2.24 | -5.78 | -7.06 | -4.85 | 4.73 |
Particulars | 10 years | 2013-09 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Shh. Funds | 380 | 329 | 49 | -388 | -792 | -704 | 766 | 653 | 647 | 689 | |
Non Curr. Liab. | 1,064 | 2,609 | 2,475 | 2,205 | 1,905 | 1,436 | 519 | 442 | 222 | 165 | |
Curr. Liab. | 3,206 | 1,123 | 1,338 | 1,541 | 2,013 | 2,346 | 175 | 142 | 241 | 372 | |
Minority Int. | 1 | ||||||||||
Equity & Liab. | 4,651 | 4,061 | 3,862 | 3,358 | 3,125 | 3,077 | 1,460 | 1,237 | 1,111 | 1,225 | |
Non Curr. Assets | 3,550 | 2,783 | 2,611 | 2,479 | 2,446 | 2,310 | 891 | 687 | 713 | 724 | |
Curr. Assets | 1,101 | 1,278 | 1,251 | 879 | 679 | 767 | 569 | 550 | 384 | 501 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 4,651 | 4,061 | 3,862 | 3,358 | 3,125 | 3,077 | 1,460 | 1,237 | 1,111 | 1,225 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-06 Rs. Cr. TTM |
Net Sales | 1,747 | 873 | 797 | 683 | 600 | 484 | 450 | 560 | 666 | 718 | |
Other Income | 42 | 25 | 19 | 20 | 17 | 24 | 15 | 9 | 19 | 18 | |
Total Income | 1,789 | 898 | 816 | 703 | 617 | 508 | 465 | 569 | 685 | 736 | |
Total Expenditure | -1,429 | -703 | -709 | -659 | -612 | -515 | -399 | -505 | -582 | -625 | |
PBIDT | 360 | 196 | 106 | 45 | 5 | -7 | 66 | 64 | 104 | 112 | |
Interest | -537 | -294 | -331 | -310 | -7 | -6 | -52 | -33 | -33 | -30 | |
Depreciation | -325 | -145 | -141 | -133 | -130 | -118 | -109 | -87 | -55 | -41 | |
Taxation | 191 | 17 | 48 | 46 | |||||||
Exceptional Items | 113 | -53 | -173 | 201 | 39 | 39 | |||||
PAT | -197 | -279 | -490 | -353 | 69 | -131 | -95 | -57 | 55 | 80 | |
Minority Interest | 1 | ||||||||||
Share Associate | 0 | -4 | -2 | -3 | |||||||
Other Related Items | |||||||||||
Consolidated Net Profit | -197 | -279 | -490 | -353 | 70 | -131 | -117 | -2 | 46 | 71 | |
Adjusted EPS | -23 | -31 | -55 | -40 | 8 | -32 | -29 | 0 | 11 | 17 |
Particulars | 10 years | 2013-09 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 168 | -369 | 212 | 317 | 9 | 12 | 81 | 24 | 92 | 18 | |
Cash Fr. Inv. | -986 | 1,334 | -1 | -9 | -28 | 45 | 167 | 67 | 113 | -31 | |
Cash Fr. Finan. | 664 | -597 | -286 | -366 | 33 | 0 | -250 | -165 | -217 | 31 | |
Net Change | -153 | 367 | -76 | -58 | 15 | 57 | -2 | -74 | -11 | 18 | |
Cash & Cash Eqvt | 23 | 391 | 315 | 257 | 35 | 92 | 90 | 16 | 4 | 23 |
Tue, 12 Sep 2023
Announcement Under Regulation 30 Of SEBI (LODR) Regulation 2015 Announcement under regulation 30 of SEBI (LODR) Regulation 2015 |
Mon, 21 Aug 2023
Announcement under Regulation 30 (LODR)-Investor Presentation Transcript of Earning Call for quarter ended June 30 2023. |
Mon, 14 Aug 2023
Announcement under Regulation 30 (LODR)-Monitoring Agency Report Monitoring Agency Report for quarter ended June 30 2023 |
Fri, 22 Sep 2023 |
|
|
|
|
|